Singh, P <br/><br/>
Serous carcinoma of the uterus-determination of HER-2/neu status using immunohistochemistry, chromogenic in situ hybridization, and quantitative polymerase chain reaction techniques: its significance and clinical correlation.  [electronic resource] 

 -  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society   
 - 1344-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-1438 
<br/><br/><label>Standard No.: </label>10.1111/j.1525-1438.2007.01181.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Disease-Free Survival<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Immunohistochemistry<br/>In Situ Hybridization<br/>Middle Aged<br/>Neoplasm Staging<br/>Polymerase Chain Reaction<br/>Proto-Oncogene Mas<br/>Receptor, ErbB-2--genetics<br/>Survival Rate<br/>Uterine Neoplasms--genetics